What medication can be given prior to surgery in Acromegaly patients?

In the context of treating acromegaly, octreotide is a somatostatin analogue that plays a critical role in managing the condition, particularly in patients scheduled for surgery. Acromegaly is often caused by excessive growth hormone secretion, typically due to a growth hormone-secreting pituitary adenoma. Preoperative treatment with octreotide can help to lower growth hormone levels and shrink the size of the tumor, making surgical resection more effective and potentially reducing the risk of complications during and after surgery.

By decreasing the secretion of growth hormone and insulin-like growth factor-1 (IGF-1), octreotide helps to stabilize the condition before surgical intervention. This not only enhances the likelihood of a successful surgical outcome but also facilitates better monitoring and management of the patient's hormonal levels. Therefore, octreotide is the preferred choice for pre-surgical preparation in acromegaly patients.